Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult ParticipantsCompleted
NCT05960032Phase 1Updated Jan 6, 2025
Sponsor: Pfizer
Healthy
China
A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy AdultsCompleted
NCT05890105Phase 1Updated Jan 3, 2025
Sponsor: Pfizer
Healthy Participants
United States
A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).Completed
NCT06029452N/AUpdated Jan 3, 2025
Sponsor: Pfizer
ATTR-CM
United States
To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell CarcinomaCompleted
NCT04682587N/AUpdated Jan 3, 2025
Sponsor: Pfizer
Renal Cell Carcinoma
United States
Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and AtherothrombosisTerminated
NCT03062319Phase 4Updated Dec 27, 2024
Sponsor: National Hospital Organization Osaka National Hospital
Ischemic Stroke · Atrial Fibrillation · Atherothrombosis
Japan
Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in IndiaCompleted
NCT04541706Phase 4Updated Dec 20, 2024
Sponsor: Pfizer
Advanced Non-Small Cell Lung Cancer
India
A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent AsthmaCompleted
NCT01152450Phase 2Updated Dec 19, 2024
Sponsor: Boehringer Ingelheim
Asthma
Austria, Czechia, Estonia, Germany, Latvia
A Study to Understand the Effect of Multiple Ascending Doses of PF-07293893 in Healthy Adult ParticipantsCompleted
NCT06177457Phase 1Updated Dec 18, 2024
Sponsor: Pfizer
Healthy Participants
United States, Belgium
A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Completed
NCT04814186Phase 4Updated Dec 18, 2024
Sponsor: Pfizer
Transthyretin Amyloid Cardiomyopathy
China
Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)Withdrawn
NCT02243852N/AUpdated Dec 18, 2024
Sponsor: University of Liverpool
Growth Hormone Deficiency
United Kingdom
A Personalized Self-Management Program for Older Adults With Chronic Pain and Negative EmotionsCompleted
NCT03487822NAUpdated Dec 18, 2024
Sponsor: Weill Medical College of Cornell University
Pain, Chronic · Negative Emotions
United States
A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).Completed
NCT05886777Phase 2Updated Dec 18, 2024
Sponsor: Pfizer
Healthy Participants
United States
A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher DiseaseCompleted
NCT04002830Phase 4Updated Dec 17, 2024
Sponsor: Ari Zimran
Gaucher Disease, Type 3
India, Israel, Turkey (Türkiye)
Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast CancerCompleted
NCT01889238Phase 2Updated Dec 13, 2024
Sponsor: Pfizer
Advanced, Androgen Receptor Positive Triple Negative Breast Cancer
United States, Belgium, Canada, Ireland, Italy +2 more
Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)Completed
NCT06525675N/AUpdated Dec 13, 2024
Sponsor: MedSIR
Metastatic Breast Cancer · Advanced Breast Cancer · Luminal Breast Cancer · HER2-negative Breast Cancer
Czechia, France, Germany, Italy, Spain +1 more
To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)Completed
NCT03644186Phase 2Updated Dec 13, 2024
Sponsor: ETOP IBCSG Partners Foundation
Breast Cancer · Estrogen Receptor Positive Tumor · HER2-positive Breast Cancer
Belgium, France, Italy, Switzerland
A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With LeiomyosarcomaTerminated
NCT04996004Phase 2Updated Dec 11, 2024
Sponsor: Pfizer
Leiomyosarcoma
United States
A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive CrisesTerminated
NCT04927247Phase 3Updated Dec 11, 2024
Sponsor: Pfizer
Sickle Cell Disease · Vaso-occlusive Crisis · Vaso-occlusive Pain Episode in Sickle Cell Disease
United States, Brazil, Colombia, France, Germany +9 more
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.Completed
NCT03329092Phase 3Updated Dec 10, 2024
Sponsor: Pfizer
Complicated Intra-abdominal Infection · Hosptial Acquired Pneumonia · Ventilator Associated Pneumonia
United States, Argentina, Bulgaria, China, Croatia +16 more
A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer PatientsCompleted
NCT01650194Phase 2Updated Dec 10, 2024
Sponsor: Astellas Pharma Global Development, Inc.
Metastatic Castration-Resistant Prostate Cancer
United States
Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in KoreaCompleted
NCT04446039N/AUpdated Dec 9, 2024
Sponsor: Pfizer
Major Depression
South Korea
Interaction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CMLRecruiting
NCT06724536N/AUpdated Dec 9, 2024
Sponsor: Carmen Fava
Leukemia,Myeloid, Chronic
Italy
The Incidence of Venous Thromboembolism in Atopic DermatitisCompleted
NCT04969653N/AUpdated Dec 9, 2024
Sponsor: Momentum Data
Venous Thromboembolism · Atopic Dermatitis · Pulmonary Embolism · Deep Vein Thrombosis
United Kingdom
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEFRecruiting
NCT05577819NAUpdated Dec 9, 2024
Sponsor: Massachusetts General Hospital
Transthyretin Amyloidosis · Heart Failure · Heart Failure, Diastolic · Amyloidosis
United States
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate CancerCompleted
NCT02918968Phase 4Updated Dec 9, 2024
Sponsor: Astellas Pharma Inc
Prostate Cancer
Japan

Previous page Next page